ArticleVaccines2024

Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response.

Krischan Braitsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.